Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.76	55.08	70.40
Graham Fair Price	40.52	5383.97	3831.35
PEG	-82.38	0.04	-0.23
Price/Book	7.26	0.35	0.32
Price/Cash Flow	63.99	-2.28	-6.33
Prices/Earnings	-46.23	4.06	7.56
Price/Sales	-39.96	2.37	3.94
Price/FCF	63.99	-2.28	-6.33
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.11	0.89	0.82
Operating Margin	-35.32	0.52	0.80
ROA	105.12	< 0.005	< 0.005
ROE	0.01	0.02	99.47
ROIC	< 0.005	0.01	35.57
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.10	2.55	-96.23
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	2.18	0.15	-93.13
EPS QOQ	-0.32	0.98	205.11
FCF QOQ	0.47	-1.96	316.34
Revenue QOQ	-0.07	0.78	1048.46
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	198.09	218.41	10.26
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.83	0.82	-1.66
Quick Ratio	0.36	0.53	44.74
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7793.48	7754.29	-0.50
Cash	9549.49	10011.26	4.84
Capex	-53.55	-19.29	63.98
Free Cash Flow	-399.45	-1183.78	-196.35
Revenue	641.94	1141.01	77.74
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	65.85	50.85	-22.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating